Sheldon L. Koenig

CIK 1766524 · President and CEO · last filed 2026-03-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.84M

Companies

2

Total Filings

28

Lifetime Open-Market Net

-$450.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ESPR President and CEO 2,172,699 $3.15 $6.84M -$450.0K 23 2026-03-18
PORTOLA PHARMACEUTICALS INC (PTLA) Delisted EVP, Chief Commercial Officer 0 $0 5 2020-07-02

Recent Filings · Page 2 of 3

28 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-05-10 ESPR Buy (P) +20,000 $25.2K EDGAR
2023-03-20 ESPR Sell (S) −6,999 -$12.5K EDGAR
2023-03-15 ESPR Grant (A) +105,000 $0 EDGAR
2023-03-08 ESPR Sell (S) −5,441 -$27.5K EDGAR
2022-09-20 ESPR Sell (S) −3,394 -$23.5K EDGAR
2022-08-08 ESPR Buy (P) +8,606 $50.0K EDGAR
2022-06-21 ESPR Sell (S) −4,552 -$22.7K EDGAR
2022-06-09 ESPR Grant (A) $0 EDGAR
2022-03-18 ESPR Sell (S) −571 -$2.6K EDGAR
2022-03-16 ESPR Grant (A) +116,000 $0 EDGAR
Showing 1120 of 28
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.